MSF's Comprehensive COVID-19 Response Efforts in Europe and Africa
MSF is actively supporting the COVID-19 response in Europe and Africa by providing case management, training/mentoring at treatment centers, screening, testing, community engagement, and research on diagnostic tests. They advocate for access to tools, address vulnerable groups, and work towards scaling up health resources amidst the pandemic.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
E N D
Presentation Transcript
Supporting Supporting the COVID the COVID- -19 response response 19 INMA VAZQUEZ, Representative to the EU and NATO DR. SALHA ISSOUFOU, Director of Operations, MSF West and Central Africa ( WaCA) February 2021
MSFs response in Europe IPC support Vulnerable groups - nursing homes - migrant population MSF and COVID 36 countries 500 health structures 137 projects case management - Ensuring continuum of regular programmes - Preparedness - Adapting context by context - Advocating for access to covid tools MSF calls for Europe s external response Global Access to COVID tools IP waiver Humanitarian buffer Scaling up resources for healh
Case Management Training/mentoring COVID-19 treatment Centre Djoungolo Hospital, Cameroon 130 Bed capacity Oxygen DRC, South Africa, Mali Support to MoH Hospital based Telemedicine Refugees Camp prevention - preparedness Ethiopia Tanzania
Screening As part of country strategy OPD Rapid Testing (DRC, Cameroun) Lesotho, Burkina Faso Screening and Testing PCR Testing Capacity Epicentre Mbarara in Uganda Eswatini Mozambique (RDT and GenXpert)
Community engagment MSF Associative Movement C te d'Ivoire Nigeria (Kano) Mali
Evaluation of Rapid Diagnostic Tests Serologic vs Antigenic Study conducted in Cameroon Good performance of Antigen tests in symptomatic patients New testing algorithms MSF and Research - Provide evidence for better management of the pandemic - Evaluate innovative and context specific tools for the response Seroprevalance surveys Burden of disease Support upcoming strategies Cameroon, Ivory Coast, DRC, Niger, Senegal, South Sudan
Human ressources and supply Borders closed Reduction of Western HR Lack of trained staff Supply shortage EPI Some Challenges and Lessons learned - Global response to the pandemic - Diversity of challenges - Diversity of responses Opportunities Empowerment of national staff Investment on local solution (EPI, gel ) E-Health (C te d Ivoire)
